145 related articles for article (PubMed ID: 7531210)
21. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
22. The relation between serum markers in the second trimester and placental pathology. A study on extremely small for gestational age fetuses.
Morssink LP; de Wolf BT; Kornman LH; Beekhuis JR; van der Hall TP; Mantingh A
Br J Obstet Gynaecol; 1996 Aug; 103(8):779-83. PubMed ID: 8760707
[TBL] [Abstract][Full Text] [Related]
23. Adverse pregnancy outcomes after a false-positive second trimester serum screen for Down syndrome in Thai pregnant women.
Sritippayawan S; Vachirasrisoontra C
J Med Assoc Thai; 2005 Apr; 88(4):449-54. PubMed ID: 16146246
[TBL] [Abstract][Full Text] [Related]
24. Unexplained elevated maternal serum alpha-fetoprotein and/or human chorionic gonadotropin and the risk of adverse outcomes.
Chandra S; Scott H; Dodds L; Watts C; Blight C; Van Den Hof M
Am J Obstet Gynecol; 2003 Sep; 189(3):775-81. PubMed ID: 14526312
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
MacDonald ML; Wagner RM; Slotnick RN
Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
[TBL] [Abstract][Full Text] [Related]
26. [Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results].
Cox M U; Kingdom J; Whittle M; McNay M; Fleming J; Bowman A; Crossley J; Aitken D
Rev Chil Obstet Ginecol; 1995; 60(3):174-80. PubMed ID: 8728745
[TBL] [Abstract][Full Text] [Related]
27. Elevated human chorionic gonadotropin levels in pregnancies with sex chromosome abnormalities.
Barnes-Kedar I; Amiel A; Maor O; Fejgin M
Am J Med Genet; 1993 Feb; 45(3):356-7. PubMed ID: 8434623
[TBL] [Abstract][Full Text] [Related]
28. Maternal serum biochemical screening for pregnancy complications other than aneuploidy.
Pahal GS; Jauniaux E
Curr Opin Obstet Gynecol; 1997 Dec; 9(6):379-86. PubMed ID: 9425582
[TBL] [Abstract][Full Text] [Related]
29. Unexplained elevated maternal serum alpha-fetoprotein levels and pregnancy outcome in twins.
Hong S; Berkowitz G; Wang W; Stone J; Ainbender E
Obstet Gynecol; 1996 Sep; 88(3):337-42. PubMed ID: 8752235
[TBL] [Abstract][Full Text] [Related]
30. Adverse perinatal outcome in patients screen-positive for neural tube defects and fetal Down syndrome.
Gross SJ; Phillips OP; Shulman LP; Bright NL; Dungan JS; Simpson JL; Elias S
Prenat Diagn; 1994 Jul; 14(7):609-13. PubMed ID: 7526367
[TBL] [Abstract][Full Text] [Related]
31. The association of triple-marker test results with adverse pregnancy outcomes in low-risk pregnancies with healthy newborns.
Sayin NC; Canda MT; Ahmet N; Arda S; Süt N; Varol FG
Arch Gynecol Obstet; 2008 Jan; 277(1):47-53. PubMed ID: 17653738
[TBL] [Abstract][Full Text] [Related]
32. Lack of association between unexplained elevated maternal serum alpha fetoprotein and/or human chorionic gonadotropin and the occurrence of placental thrombotic lesions.
Salim R; Okopnik M; Garmi G; Nachum Z; Zafran N; Shalev E
Placenta; 2010 Apr; 31(4):277-81. PubMed ID: 20132984
[TBL] [Abstract][Full Text] [Related]
33. Abnormal maternal serum alpha fetoprotein and pregnancy outcome.
Zarzour SJ; Gabert HA; Diket AL; St Amant M; Miller JM
J Matern Fetal Med; 1998; 7(6):304-7. PubMed ID: 9848697
[TBL] [Abstract][Full Text] [Related]
34. Outcome of pregnancies with elevation of both maternal serum alpha-fetoprotein and human chorionic gonadotropin.
Kuller JA; Sellati LE; Chescheir NC; Helwick JJ; Lincoln-Boyea B; Boor-Smith C; McCoy MC; Katz VL
Am J Perinatol; 1995 Mar; 12(2):93-7. PubMed ID: 7540011
[TBL] [Abstract][Full Text] [Related]
35. Combined ultrasonography and amniocentesis for pregnant women with elevated serum alpha-fetoprotein. Revising the risk estimate.
Schell DL; Drugan A; Brindley BA; Zador IE; Johnson MP; Schwartz DB; Evans MI
J Reprod Med; 1990 May; 35(5):543-6. PubMed ID: 1693689
[TBL] [Abstract][Full Text] [Related]
36. Adverse outcome of pregnancies with extremely high levels of maternal serum human chorionic gonadotropin.
Sharony R; Itzhaky D; Amiel A; Hershko A; Grinshpoon Y; Fejgin M
Fetal Diagn Ther; 2008; 23(3):233-6. PubMed ID: 18417984
[TBL] [Abstract][Full Text] [Related]
37. Maternal serum alpha-fetoprotein screening: report of a Canadian pilot project.
Doran TA; Valentine GH; Wong PY; Wielgosz G; Benzie RJ; Soltan HC; Jenner MR; Morland PA; Montgomery RJ; Allen LC
CMAJ; 1987 Aug; 137(4):285-93. PubMed ID: 2440547
[TBL] [Abstract][Full Text] [Related]
38. Maternal serum levels of alpha-fetoprotein and fetal fibronectin as markers of labor in the third trimester.
Khandelwal M; Lynch L; Lockwood CJ; Ainbender E
Am J Perinatol; 1995 May; 12(3):161-3. PubMed ID: 7541997
[TBL] [Abstract][Full Text] [Related]
39. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly.
Celentano C; Guanciali-Franchi PE; Liberati M; Palka C; Fantasia D; Morizio E; Calabrese G; Stuppia L; Rotmensch S
Prenat Diagn; 2005 Mar; 25(3):220-4. PubMed ID: 15791663
[TBL] [Abstract][Full Text] [Related]
40. Maternal serum screening for neural tube defects and fetal chromosome abnormalities.
Rose NC; Mennuti MT
West J Med; 1993 Sep; 159(3):312-7. PubMed ID: 7694429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]